Master
Content
- "Comprehensive profiling of DNA repair defects in breast cancer identifies a novel class of endocrine therapy resistance drivers." Clinical Cancer Research.2018/May;: Pubmed PMID: 29793947
- "Immune Checkpoint Profiles in Luminal B Breast Cancer (Alliance)." 2019/October30;: Pubmed PMID: 31665365
- "The prognostic effects of somatic mutations in ER-positive breast cancer." Nature Communications.2018/September;: Pubmed PMID: 30181556
- "Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy." 2020;: Pubmed PMID: 33212010
- "Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer” 2022;” PubmedPMID: 36001024
